Feng Chen
Capital Medical University
15 Papers
29 Citations
Feng Chen is an academic researcher from Capital Medical University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 4, co-authored 9 publications.
Chat about Author
Papers
Ferroptosis-related gene signature as a prognostic marker for lower-grade gliomas.
TL;DR: In this paper, the prognostic value of 12 ferroptosis-related genes was investigated in lower-grade gliomas (LGG) using stepwise multivariate Cox regression.
32
Liposomal honokiol promotes hair growth via activating Wnt3a/β-catenin signaling pathway and down regulating TGF-β1 in C57BL/6N mice.
Shenglan Li,Jinyi Chen,Feng Chen,Ce Wang,Xiaodi Guo,Can Wang,Yaqiong Fan,Yali Wang,Yichen Peng,Wenbin Li +9 more
TL;DR: In this article, the effect of liposomal honokiol (Lip-honokiol) on inducing hair anagen was investigated and the hair grew out in advance in the shaving area of C57BL/6N mice after daily abdominal injection.
21
Efficacy and safety of chimeric antigen receptor-T cells in the treatment of B cell lymphoma: a systematic review and meta-analysis.
TL;DR: CAR-T cell treatment is safe for clinical application; however, toxicity effects should be monitored.
20
The Efficacy and Safety of Cytarabine on Newly Diagnosed Primary Central Nervous System Lymphoma: A Systematic Review and Meta-Analysis
TL;DR: A meta-analysis verifies that adding cytarabine to the therapeutic regimen is helpful for newly diagnosed PCNSL patients in terms of CR, ORR, and PFS, and it should be noted that the grade 3–4 toxic effects, especially hematological toxicity, are higher in the cy tarabine group than that of the cytar abine-free group.
A Novel Classification of Glioma Subgroup, Which Is Highly Correlated With the Clinical Characteristics and Tumor Tissue Characteristics, Based on the Expression Levels of Gβ and Gγ Genes
TL;DR: In this paper, a new subgroup classification for glioma based on the expression levels of Gβ and Gγ genes was proposed to complement studies on Glioma and Gβγ subunits, and to support clinicians to assess a patient's tumor status.